Zone 2 benefits: what the research supports—and what it doesn't
Regular physical activity has well-established health benefits. That does not mean every benefit is uniquely caused by zone 2, or that one heart-rate range guarantees longevity. Read the evidence at the level of the claim it actually tested.
Three claims that should not be blended together
The first claim is that being physically active benefits health. The second is that a particular low-intensity training approach produces a particular adaptation. The third is that an app's zone 2 total predicts how long someone will live. Evidence for the first claim does not automatically establish the second or third.
Base tracks a part of your activity. It is not a medical device and has not been shown in a clinical trial to extend life, prevent disease or guarantee a particular fitness outcome.
| Claim | What would support it? |
|---|---|
| Activity benefits health | Public-health evidence across activity patterns |
| One intensity is optimal | Direct comparisons relevant to the population and outcome |
| An app extends life | Evidence evaluating that intervention and outcome |
A strong foundation: general physical activity
WHO and CDC guidance support regular aerobic activity and include strength work as part of the broader recommendation. This is a sound foundation for encouraging an active life without promising that one narrow training zone is the whole answer.
The practical appeal of a manageable routine is that it may be easier to fit into real life. That is a reason to design a useful habit tool, not evidence that Base improves adherence or health outcomes for every user.
Evidence: WHO: physical activity and sedentary behaviour guidelines · CDC: adult activity recommendations
Healthy aging: a meaningful result, with limits
The LIFE trial randomized 1,635 sedentary adults aged 70–89 who had physical limitations but could walk 400 metres. A structured program combining aerobic, resistance and flexibility activities reduced major mobility disability compared with a health-education program over an average 2.6 years.
That is relevant to the broader story of staying capable as we age. But the trial did not isolate zone 2, test Base, or establish that 150 minutes in a watch zone guarantees being able to climb stairs at 80. Its result should stay attached to its population and intervention.
Evidence: Pahor et al. (2014): the LIFE randomized clinical trial
Mitochondria and fat oxidation: avoid ‘best’ by default
Popular explanations often move from a plausible physiological mechanism to a claim that zone 2 is the best exercise for everyone. A 2025 narrative review, Much Ado About Zone 2, challenges that conclusion for mitochondrial and fatty-acid oxidative capacity in the general population.
The review argues that evidence for higher intensities matters, especially when training volume is limited. That does not make low-intensity exercise worthless. It means the strongest defensible message is more nuanced than ‘only zone 2 works.’ Fuel use during a workout is also not the same outcome as long-term body-fat loss.
Evidence: Much Ado About Zone 2 (2025)
A precise-looking heart-rate range can still be an estimate
Meixner and colleagues compared zone-intensity markers in 50 cyclists. The markers varied meaningfully, and fixed percentages of maximum heart rate could fail to reflect an individual's metabolic response precisely.
The study is useful when explaining why devices and calculators disagree. It does not prove that a consumer formula, including one used by Base, measures an individual's physiological threshold with clinical accuracy.
Evidence: Meixner et al. (2025): individual variability in zone 2 intensity markers
The promise we can make about the product
Base is being built to gather qualifying minutes from recorded workouts into one understandable weekly view, with health data processed on your devices. That is a product function we can explain without converting scientific associations into personal promises.
We link to original evidence, distinguish study types and explain limitations. These articles are written by Base Cardio, not presented as independently medically reviewed. The editorial policy explains our commercial interest and how to report an error.
The useful next step is not to chase a lifespan number. It is to find an appropriate routine, understand how the activity is being counted and keep the broader picture of health in view.
Sources & further reading
Source types matter: public-health guidance, product documentation and individual studies answer different questions. These sources do not endorse Base.
- WHO: physical activity and sedentary behaviour guidelinesPublic-health guidance
- CDC: adult activity recommendationsPublic-health guidance
- Pahor et al. (2014): the LIFE randomized clinical trialRandomized trial · adults aged 70–89
- Much Ado About Zone 2 (2025)Narrative review · not a randomized trial
- Meixner et al. (2025): individual variability in zone 2 intensity markersLaboratory study · 50 cyclists
From one workout to a weekly habit
Base is a zone 2 cardio tracker for iPhone and Apple Watch, designed to gather supported minutes from your recorded workouts into a weekly view. Health data stays on your devices. Base is preparing for launch; joining the list below is not an app download.